| JYSB2200166 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-08-24 | | Bayer Healthcare LLC | | | view |
| JYSB2400050 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2024-03-07 | | Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG | | | view |
| JYSB1800188 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2018-09-10 | | Wyeth Farma SA;Pfizer Ltd | Certificate Issued | 2019-02-02 | view |
| CXSS2101029 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(3.4) | New Drug Application | 2021-09-14 | | Hualan Biological Engineering Chongqing Co Ltd | | | view |
| CYSB2200145 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-06-08 | | Shanghai RAAS Blood Products Co Ltd | | | view |
| JYSB1800047 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2018-03-26 | | Bayer Healthcare LLC | Certificate Issued | 2018-07-27 | view |
| CXSL2101301 | 人凝血因子Ⅷ/血管性血友病因子复合物 | | Lyophilized | Biological Products(3.2) | New Drug Application | 2021-09-02 | | Shandong Taibang Biological Products Co Ltd | | | view |
| JYSB1500115 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2015-04-24 | | Wyeth Farma SA;Wyeth Pharmaceuticals Inc | Certificate Issued | 2015-10-29 | view |
| JYSB2500024 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2025-02-08 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |
| JYSB1900244 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2019-09-05 | | Wyeth Farma SA;Pfizer Ltd | Filed | 2019-09-16 | view |
| JYSB2000569 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2020-11-18 | | Baxter AG;Baxalta Manufacturing Sàrl | Filed | 2020-12-01 | view |
| JXSS1000006 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2010-06-21 | | Baxter SA;Baxter AG | Certificate Issued | 2012-05-10 | view |
| JXSL2200160 | 注射用培重组人凝血因子Ⅷ | | Lyophilized | Biological Products(3.1) | Import Drug Application | 2022-09-09 | | Baxalta Us Inc;Takeda (China) International Trading Co Ltd | | | view |
| CYSB2400133 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(原10) | Supplementary Application | 2024-05-24 | | SinoCelltech Ltd | | | view |
| JYSB1600273 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2017-01-03 | | Wyeth Farma SA;Wyeth Pharmaceuticals Inc | Certificate Issued | 2017-04-10 | view |
| JXSL0900029 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2009-05-11 | | Wyeth Pharmaceuticals Inc | Certificate Issued | 2010-05-27 | view |
| JXSS2200002 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(3.1) | Import Drug Application | 2022-01-26 | | Octapharma Ab Sweden;Sichuan Sinco Pharmaceutical Co Ltd | | | view |
| JYSB2300036 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2023-02-23 | | Bayer Healthcare LLC | | | view |
| JYSB1800114 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2018-05-17 | | Baxter AG;Baxalta Manufacturing Sàrl | Filed | 2018-05-30 | view |
| JXSL1600037 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2016-07-11 | | Bayer Pharma AG | Certificate Issued | 2018-07-27 | view |
